Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5205189
Max Phase: Preclinical
Molecular Formula: C45H40F3N7O6S
Molecular Weight: 863.92
Associated Items:
ID: ALA5205189
Max Phase: Preclinical
Molecular Formula: C45H40F3N7O6S
Molecular Weight: 863.92
Associated Items:
Canonical SMILES: Nc1sc(-c2ccc(C(=O)NCCCCc3ccc(Nc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)cc3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1
Standard InChI: InChI=1S/C45H40F3N7O6S/c46-45(47,48)30-11-6-10-29(21-30)33-34(36(57)26-8-2-1-3-9-26)40(49)62-39(33)27-14-16-28(17-15-27)43(60)50-20-5-4-7-25-12-18-31(19-13-25)54-41-35-42(52-23-51-41)55(24-53-35)44-38(59)37(58)32(22-56)61-44/h1-3,6,8-19,21,23-24,32,37-38,44,56,58-59H,4-5,7,20,22,49H2,(H,50,60)(H,51,52,54)/t32-,37-,38-,44-/m1/s1
Standard InChI Key: JVRYIHJSTPTCCL-LJJXTENRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 863.92 | Molecular Weight (Monoisotopic): 863.2713 | AlogP: 7.16 | #Rotatable Bonds: 14 |
Polar Surface Area: 197.74 | Molecular Species: NEUTRAL | HBA: 13 | HBD: 6 |
#RO5 Violations: 4 | HBA (Lipinski): 13 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 4 |
CX Acidic pKa: 12.45 | CX Basic pKa: 3.46 | CX LogP: 7.55 | CX LogD: 7.55 |
Aromatic Rings: 7 | Heavy Atoms: 62 | QED Weighted: 0.05 | Np Likeness Score: -0.28 |
1. Awalt JK, Nguyen ATN, Fyfe TJ, Thai BS, White PJ, Christopoulos A, Jörg M, May LT, Scammells PJ.. (2022) Examining the Role of the Linker in Bitopic N6-Substituted Adenosine Derivatives Acting as Biased Adenosine A1 Receptor Agonists., 65 (13.0): [PMID:35729775] [10.1021/acs.jmedchem.2c00320] |
Source(1):